19 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... therapy for purulent meningitis ... condition #IDSA ... #Meningitis #Antibiotics ... #Pharmacology #Management
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
therapy in bacterial meningitis ... #IDSA #Meningitis ... #Pharmacology #Management
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... - 4–6 weeks Alternatives ... Meningoencephalitis #IDSA ... #Treatment #management ... #meningitis #cryptococcus
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... Infection General Management ... malabsorption Alternative ... IsosporaBelli #IDSA ... Prevention #Treatment #management
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... (IDSA 2021): ... bid x 10d - Alternative ... /severe CDI IDSA ... infectiousdiseases #IDSA
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... daily (AI), or Alternative ... candida #mucosal #IDSA ... Prevention #Treatment #management
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... diarrhea as an alternative ... Enteric #Bacterial #IDSA ... Prevention #Treatment #management
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... for 30–60 days Alternative ... Trypanosomiasis #IDSA ... Prevention #Treatment #management
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... day) 2 weeks Alternatives ... Meningoencephalitis #IDSA ... #Treatment #management ... #meningitis #cryptococcus
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis - Induction, Consolidation and Maintenance Therapy

Table 2. Antifungal Treatment Recommendations
IDSA Treatment Recommendations ... Meningoencephalitis #IDSA ... #Treatment #management ... #meningitis #cryptococcus